Welcome to our dedicated page for Cno Finl Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CNO Financial Group, Inc. (NYSE: CNO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As a life and health insurer and financial services provider focused on middle-income America, CNO uses its filings to present detailed information on its insurance products, capital position and operating performance.
Investors can review CNO’s current reports on Form 8-K, which the company uses to furnish quarterly earnings press releases, quarterly financial supplements and additional financial and operating data. These filings commonly include metrics such as net income, net operating income, income from insurance products across annuity, health and life lines, fee income, investment income not allocated to product lines, and measures like book value per share and operating return on equity.
Over time, CNO’s SEC filings also provide insight into capital management and structure, including common stock dividends, share repurchase activity, reinsurance transactions with its wholly owned Bermuda reinsurance company, and technology modernization initiatives such as the TechMod project. Filings may describe changes in business mix, such as the decision to exit the fee services side of the Worksite Division to focus on core insurance offerings.
On Stock Titan, AI-generated highlights help explain the key points in lengthy documents, so users can quickly understand what each filing means for CNO’s insurance operations, investment portfolio and shareholders. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while tools for viewing insider-related information, capital actions and recurring reporting patterns make it easier to analyze CNO’s regulatory history.
CNO Financial Group, Inc. executive Karen J. DeToro, President of the Worksite Division, surrendered 4,056 shares of common stock at $40.61 per share to the company to cover required tax withholding on vested restricted stock units. This was a tax-withholding disposition, not an open-market sale. After the transaction, she directly holds 50,524 common shares.
CNO Financial Group Chief Executive Officer Gary C. Bhojwani reported a tax-related share disposition. On March 25, 2026, he surrendered 45,746 shares of Common Stock at $40.61 per share to the company to cover required tax withholding on vested restricted stock units.
After this withholding transaction, Bhojwani directly owned 231,780 shares of CNO common stock and indirectly owned 635,471 shares through the Gary C. Bhojwani Revocable Trust. The Form 4 does not show any open-market purchase or sale; the reported disposition reflects a compensation-related tax payment mechanism.
CNO Financial Group Inc reports a Schedule 13G/A from The Vanguard Group showing zero shares beneficially owned. The filing states that, following an internal realignment on 01/12/2026, certain Vanguard subsidiaries now report separately and The Vanguard Group no longer beneficially owns the securities held by those subsidiaries. The Schedule 13G/A lists amount beneficially owned: 0 and percent of class: 0%. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
CNO Financial Group calls a virtual annual shareholder meeting for May 12, 2026, asking investors to elect nine directors, approve say-on-pay and ratify PricewaterhouseCoopers as 2026 auditor. The Board recommends voting FOR all proposals.
For 2025, CNO reported net income of $229.3 million ($2.30 per diluted share), down from $420.8 million in 2024 due to market-related accounting impacts and goodwill and intangible impairments. Net operating income was $439.2 million ($4.40 per diluted share) and operating return on equity excluding significant items was 11.4%. Total new annualized premium rose 15%, with records in both Consumer and Worksite divisions.
CNO generated $365.5 million in free cash flow and returned $386.1 million to shareholders in 2025, including $319.9 million of share repurchases that cut the weighted average diluted share count by 8% and $66.2 million in dividends. Over 10 years, it has returned $3.0 billion, reducing share count by 49%. Year-end 2025 metrics included $351 million of unrestricted cash and investments at CNO and its non-insurance subsidiaries, a consolidated risk-based capital ratio of 380%, book value per diluted share excluding accumulated other comprehensive income of $38.81, and a debt-to-total-capital ratio excluding accumulated other comprehensive income of 26.2%.
CNO Financial Group President, Consumer Division Scott L. Goldberg reported routine option exercises paired with share sales. On March 19 and 20, he exercised employee stock options for a total of 22,120 shares of common stock at an exercise price of $21.06 per share. He then sold the 22,120 shares in open-market transactions at weighted average prices of $39.97 and $39.54 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 6, 2025. Following these transactions, Goldberg directly holds 214,524 shares of CNO Financial Group common stock.
CNO Financial Group submitted a Rule 144 notice reporting the proposed sale of 11,060 common shares.
The filing identifies Scott Goldberg as the holder and lists a stock option exercise with a sale date of 03/20/2026, settlement as cash, and prior sales of 11,060 shares on 03/19/2026 for $442,078.15.
CNO Financial Group reports 2025 results showing a sizable, diversified insurance platform focused on middle‑income pre‑retirees and retirees. As of December 31, 2025, the company had total assets of $38.8 billion, shareholders’ equity of $2.6 billion and revenues of $4.5 billion, generating net income of $229.3 million.
Total 2025 premium collections were $4.5913 billion, led by annuities at $1,943.3 million, health at $1,663.5 million and life at $984.5 million. CNO distributes products through Consumer and Worksite divisions, relies heavily on fixed indexed annuities and supplemental health, and plans to exit Worksite fee services in 2026 to emphasize core insurance operations.
CNO Financial Group General Counsel Matthew J. Zimpfer reported option exercises and related stock sales. On February 17 and 18, 2026, he exercised employee stock options covering 57,370 shares of common stock and acquired the same number of shares through derivative exercises.
On those same dates, he sold a total of 57,370 shares of CNO common stock in open-market transactions at weighted average prices of $43.1656 and $43.0515 per share, pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025. Following these transactions, he directly owned 307,937 shares of CNO common stock.